Full Text
PCSK9 Inhibitors - Alirocumab and Evolucumab- Key Insights on Differentiation in a Generic Market

Abstract

Authors

S Kochel M Mwamburi

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×